Stay updated on Nivolumab in Untreated Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Untreated Lung Cancer Clinical Trial page.

Latest updates to the Nivolumab in Untreated Lung Cancer Clinical Trial page
- Check3 days agoChange DetectedNew revision label added: Revision: v3.3.4 replaces v3.3.3, representing a minor UI update that does not affect the study content or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedLocations section now lists Texas (Houston, MD Anderson Cancer Center). Page revision updated to v3.3.3.SummaryDifference0.2%

- Check53 days agoChange DetectedAdded a note that publications are automatically filled from PubMed and updated the revision to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check60 days agoChange DetectedRemoved the government funding lapse notice regarding NIH operations; the study details page now presents the trial information without that notice.SummaryDifference0.3%

- Check75 days agoChange DetectedCore study details such as title, conditions, locations, eligibility criteria, and primary outcomes remain unchanged, while minor formatting/layout tweaks and the addition of a results section were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check103 days agoChange DetectedMajor change: page now advertises a government operating-status notice and updates the release version to v3.2.0; the previous v3.1.0 version tag was removed.SummaryDifference2%

Stay in the know with updates to Nivolumab in Untreated Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Untreated Lung Cancer Clinical Trial page.